ArticleScientific reports2026
Retinal blood flow increases with diabetic retinopathy severity in type 2 diabetes: a cross-sectional study using laser doppler velocimetry.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hemodynamic phenotypes defined by arterial stiffness index and pulse pressure with risk of diabetic microvascular complications in type 2 diabetes.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinal arterial blood flow is known to be reduced in patients with type 2 diabetes mellitus (T2D) No Diabetic Retinopathy (NDR) compared with healthy individuals, yet the hemodynamic changes across the early stages of diabetic retinopathy (DR) remain unclear. This cross-sectional study investigated the association between retinal blood flow (RBF) and DR severity in patients with T2D using laser Doppler velocimetry, which provides absolute measurements of retinal arterial diameter, flow velocity, and volumetric blood flow. A total of 419 participants were included and classified as NDR (n = 323), mild non-proliferative DR (NPDR; n = 60), moderate NPDR (n = 8), or severe NPDR (n = 28). Median RBF increased progressively with DR severity, measuring 9.8, 10.6, 11.9, and 11.6 μl/min, respectively. Trend analysis using the Jonckheere-Terpstra test demonstrated a significant positive association between RBF and DR stage (p = 0.035). These findings suggest that while RBF is reduced in the earliest stage of diabetes, it subsequently increases with worsening retinopathy, potentially reflecting impaired retinal autoregulation and pressure-dependent hyperperfusion. Measurement of retinal arterial blood flow may therefore serve as a potential hemodynamic marker associated with DR severity in T2D.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.